Will you have Granulopenia with Erythremia - from FDA reports

Summary

Granulopenia is found among people with Erythremia, especially for people who are male, 60+ old, take medication Vidaza and have Acute myeloid leukaemia. This study is created by eHealthMe based on reports of 11 people who have Erythremia from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on Granulopenia and Erythremia, and their synonyms.

What is Erythremia?

Erythremia (condition of increase in total blood volume) can be treated by Coumadin, Hydrea, Hydroxyurea (latest reports from 939 Erythremia patients)

What is Granulopenia?

Granulopenia (low white blood cell count) has been reported by people with multiple myeloma, schizophrenia, breast cancer, preventive health care, high blood pressure (latest reports from 102,920 Granulopenia patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 25, 2019

11 people who have Erythremia and Granulopenia are studied.


Number of reports submitted per year:

Would you have Granulopenia when you have Erythremia?

Gender of people who have Erythremia and experience Granulopenia *:

  • female: 50 %
  • male: 50 %

Age of people who have Erythremia and experience Granulopenia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 16.67 %
  • 50-59: 0.0 %
  • 60+: 83.33 %

Top co-existing conditions for these people *:

  1. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 27.27%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 27.27%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 9.09%
  4. Essential Thrombocythaemia (chronic blood cancer): 1 person, 9.09%
  5. Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 1 person, 9.09%

Most common drugs for these people *:

  1. Vidaza: 3 people, 27.27%
  2. Jakafi: 2 people, 18.18%
  3. Tracleer: 1 person, 9.09%
  4. Thalomid: 1 person, 9.09%
  5. Protonix: 1 person, 9.09%
  6. Pegasys: 1 person, 9.09%
  7. Neupogen: 1 person, 9.09%
  8. Mycophenolate Mofetil: 1 person, 9.09%
  9. Humalog: 1 person, 9.09%
  10. Coumadin: 1 person, 9.09%

Top symptoms for these people *:

  1. Thrombocytopenia (decrease of platelets in blood): 9 people, 81.82%
  2. Disease Progression: 4 people, 36.36%
  3. Leukopenia (less number of white blood cells in blood): 4 people, 36.36%
  4. Anaemia (lack of blood): 4 people, 36.36%
  5. Fatigue (feeling of tiredness): 4 people, 36.36%
  6. Death: 3 people, 27.27%
  7. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 18.18%
  8. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 18.18%
  9. General Physical Health Deterioration (weak health status): 2 people, 18.18%
  10. Haematotoxicity (toxins that destroy red blood cells): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.



Do you have Granulopenia with Erythremia?

You are not alone:




Related studies

Drugs that are associated with Granulopenia
Granulopenia (2,540 drugs)
Other conditions that could cause Granulopenia
Granulopenia (2,796 conditions)
Browse all symptoms of Erythremia
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you have Granulopenia and Erythremia



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.